Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RRP9 |
| Upstream (Parents) |
|---|
| (<<) BCL6 → RRP9 |
| (<<) CD3EAP → RRP9 |
| (<<) E2F5 → RRP9 |
| (<<) E2F6 → RRP9 |
| (<<) HRAS → RRP9 |
| (<<) LCP1 → RRP9 |
| (<<) NXT1 → RRP9 |
| (<<) ODC1 → RRP9 |
| (<<) PIP4K2A → RRP9 |
| (<<) PLCG2 → RRP9 |
| (<<) PNO1 → RRP9 |
| (<<) STAT4 → RRP9 |
| (<<) TCF7L1 → RRP9 |
| (<<) TUBA4A → RRP9 |
| Downstream (Children) |
|---|
| RRP9 → CBFA2T3 (>>) |
| RRP9 → CISH (>>) |
| RRP9 → ILKAP (>>) |
| RRP9 → MYCN (>>) |
| RRP9 → PFDN2 (>>) |
| RRP9 → PIK3R5 (>>) |
| RRP9 → RHBDL1 (>>) |
| RRP9 → RPL26L1 (>>) |
| RRP9 → SDK2 (>>) |
| RRP9 → SMAD7 (>>) |
| RRP9 → TIMM13 (>>) |
| RRP9 → VANGL1 (>>) |
| RRP9 → YRDC (>>) |
